Article
Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer.
European urology - 1 Aug 2018
Mahal Brandon A, Yang David D, Wang Natalie Q, Alshalalfa Mohammed, Davicioni Elai, Choeurng Voleak, Schaeffer Edward M, Ross Ashley E, Spratt Daniel E, Den Robert B, Martin Neil E, Mouw Kent W, Orio Peter F, Choueiri Toni K, Taplin Mary-Ellen, Trinh Quoc-Dien, Feng Felix Y, Nguyen Paul L
Abstract excerpt
BACKGROUND: The consequences of low prostate-specific antigen (PSA) in high-grade (Gleason 8-10) prostate cancer are unknown. OBJECTIVE: To evaluate the clinical implications and genomic features of low-PSA, high-grade disease. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective study of clinical data for 494 793 patients from the National Cancer Data Base and 136 113 patients from the Surveillance,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.